Vontier Corp. (VNT) Reports In-Line Q3 EPS; Offers FY22 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Savient Pharmaceuticals, Inc. (NYSE: VNT) | Delayed: 36.56 -0.27 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.83 | 52 Week High | $9.92 | |||
| Open | $36.80 | 52 Week Low | $9.10 | |||
| Day High | $37.20 | P/E | N/A | |||
| Day Low | $36.54 | EPS | $-0.94 | |||
| Volume | 1,426,204 | |||||
